Viewing StudyNCT00236626

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 12:05 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00236626
Status: COMPLETED
Last Update Posted: 2011-06-08
First Post: 2005-10-07
Brief Title: A Study of the Safety and Effectiveness of Topiramate on Insulin Sensitivity in Overweight or Obese Patients With Type 2 Diabetes
Sponsor: Johnson Johnson Pharmaceutical Research Development LLC
Organization: Johnson Johnson Pharmaceutical Research Development LLC
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Obesity
Diabetes Mellitus Type 2
Diabetes Mellitus Adult-Onset
Keywords:
Name View
Metabolic Syndrome View
Type 2 Diabetes View
Obesity View
Insulin Resistance View
Body Mass Index View
Hypertension View
Hyperlipidemia View
Sulfonylurea View
Topiramate View
Adult-Onset Diabetes Mellitus View